Brought to you by 
Albany Molecular Research completes $46.5mm IPO
09 Mar 2000
Executive Summary
Albany Molecular Research, a chemistry outsourcing company, netted $46.5mm in a 2.5mm share IPO at $20 each. Originally the offering was for 2.2mm shares at $17-19 apiece, but the offering was increased to meet investor demand.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Albany Molecular Research completes $46.5mm IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice